OSL:AZT - Euronext Oslo - NO0010014632 - Common Stock - Currency: NOK
OSL:AZT (5/30/2025, 7:00:00 PM)
15.85
+0.05 (+0.32%)
The current stock price of AZT.OL is 15.85 NOK. In the past month the price decreased by -3.34%. In the past year, price decreased by -37.89%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 17.96 | 288.63B | ||
AMG.DE | AMGEN INC | 13.69 | 135.45B | ||
GIS.DE | GILEAD SCIENCES INC | 14.12 | 120.45B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 99.93B | ||
1REGN.MI | REGENERON PHARMACEUTICALS | 13.73 | 58.22B | ||
ARGX.BR | ARGENX SE | 106.84 | 30.92B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 20.29B | ||
IDP.DE | BIOGEN INC | 8.2 | 16.85B | ||
1BMRN.MI | BIOMARIN PHARMACEUTICAL INC | 33.78 | 9.98B | ||
1MRNA.MI | MODERNA INC | N/A | 9.15B | ||
0QF.DE | MODERNA INC | N/A | 8.90B | ||
BIO.DE | BIOTEST AG | 65.85 | 1.69B |
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
ARCTICZYMES TECHNOLOGIES ASA
Sykehusveien 23
Tromso TROMS NO
Employees: 53
Phone: 4777648900
The current stock price of AZT.OL is 15.85 NOK. The price increased by 0.32% in the last trading session.
The exchange symbol of ARCTICZYMES TECHNOLOGIES ASA is AZT and it is listed on the Euronext Oslo exchange.
AZT.OL stock is listed on the Euronext Oslo exchange.
6 analysts have analysed AZT.OL and the average price target is 19.38 NOK. This implies a price increase of 22.27% is expected in the next year compared to the current price of 15.85. Check the ARCTICZYMES TECHNOLOGIES ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a market capitalization of 809.46M NOK. This makes AZT.OL a Small Cap stock.
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) currently has 53 employees.
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a support level at 15.24 and a resistance level at 15.89. Check the full technical report for a detailed analysis of AZT.OL support and resistance levels.
The Revenue of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is expected to grow by 8.45% in the next year. Check the estimates tab for more information on the AZT.OL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AZT.OL does not pay a dividend.
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) will report earnings on 2025-08-14.
The PE ratio for ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 792.5. This is based on the reported non-GAAP earnings per share of 0.02 and the current share price of 15.85 NOK. Check the full fundamental report for a full analysis of the valuation metrics for AZT.OL.
ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL. AZT.OL has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months AZT.OL reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS decreased by -93.94% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.12% | ||
ROA | 2.45% | ||
ROE | 2.61% | ||
Debt/Equity | 0.01 |
ChartMill assigns a Buy % Consensus number of 77% to AZT.OL. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 26.25% and a revenue growth 8.45% for AZT.OL